Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics.Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent $60.25…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
